What is Blueleaf?
Blueleaf Incorporated is a specialized process engineering company headquartered in New England, focusing on the execution of pilot studies for advanced water and wastewater treatment systems. Over the past three years, the company has successfully completed more than 60 pilot studies, addressing the removal of diverse contaminants from potable water and nutrient reduction in wastewater. Blueleaf serves a clientele comprising consulting engineers and treatment system manufacturers, providing them with independent evaluations and enhancing their competitive edge through proprietary expertise. The company leverages sophisticated statistical analysis and experimental design methodologies to optimize water treatment processes and elevate overall water quality standards.
How much funding has Blueleaf raised?
Blueleaf has raised a total of $95K across 1 funding round:
Debt
$95K
Debt (2021): $95K with participation from PPP
Key Investors in Blueleaf
PPP
Public-Private Partnership
What's next for Blueleaf?
Operating at a significant Series B/C stage, Blueleaf's recent influx of substantial expansion capital is poised to fuel strategic initiatives. This financing is expected to support the scaling of its pilot study operations, potentially expanding its geographical reach and technological capabilities. The company is likely to invest in further research and development to enhance its offerings in contaminant removal and nutrient management, solidifying its position as a key player in the water and wastewater treatment sector. The focus will be on translating its proven expertise into broader market adoption and developing innovative solutions for increasingly complex environmental challenges.
See full Blueleaf company page
